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Synaptic cell adhesion molecules (CAMs) are known
to play key roles in various aspects of synaptic struc-
tures and functions, including early differentiation,
maintenance, and plasticity.We herein report the iden-
tification of a family of cell adhesion-like molecules
termed SALM that interacts with the abundant post-
synaptic density (PSD) protein PSD-95. SALM2,
a SALM isoform, distributes to excitatory, but not in-
hibitory, synaptic sites. Overexpression of SALM2 in-
creases the number of excitatory synapses and den-
dritic spines. Mislocalized expression of SALM2
disrupts excitatory synapses and dendritic spines.
Bead-induced direct aggregation of SALM2 results in
coclustering of PSD-95 and other postsynaptic pro-
teins, including GKAP and AMPA receptors. Knock-
down of SALM2 by RNA interference reduces the num-
ber of excitatory synapses and dendritic spines and
the frequency, but not amplitude, of miniature excit-
atory postsynaptic currents. These results suggest
that SALM2 is an important regulator of the differenti-
ation of excitatory synapses.
Introduction
The early stages of synaptic differentiation are thought to
involve a series of events including the initial contact be-
tween the pre- and postsynaptic sides, trans-synaptic
adhesion, and the recruitment of synaptic proteins to
*Correspondence: kime@kaist.ac.krearly synapses. Synaptic cell adhesion molecules
(CAMs) play key roles in these processes and also func-
tion in the maintenance and activity-dependent changes
of established synapses (Craig et al., 2006; Dean and
Dresbach, 2006; Funke et al., 2004; Levinson and El-Hus-
seini, 2005; Li and Sheng, 2003; Scheiffele, 2003; Waites
et al., 2005; Washbourne et al., 2004; Yamagata et al.,
2003; Yuste and Bonhoeffer, 2004).
Previous studies have identified several synaptic
CAMs, including neuroligin, SynCAM, Sidekick, cad-
herin, protocadherin, and NCAM (Biederer et al., 2002;
Ichtchenko et al., 1995; Kohmura et al., 1998; Wash-
bourne et al., 2004; Wu and Maniatis, 1999; Yamagata
et al., 2002, 2003). Each of these synaptic CAMs differ
in terms of homo/heterophilic adhesion, calcium sensi-
tivity, and synaptic/extrasynaptic localization and are
thought to act in different processes, such as recognition
of target domains within a neuron, synaptic differentia-
tion, synaptic stability, and plastic changes in synapses.
Synaptic differentiation by CAMs is likely to involve
trans-synaptic adhesion between pre- and postsynaptic
CAMs and subsequent recruitment of synaptic proteins.
An ideal synaptic CAM for synaptic differentiation may
have two characteristics. First, it should mediate a heter-
ophilic adhesion, because different CAMs in pre- and
postsynaptic sides may allow dendrites and axons to
efficiently find partners without self-adhesion. Second,
the prototypical CAM should interact with an appropriate
cytosolic scaffolding protein capable of recruiting a
variety of synaptic proteins to the early synapse.
Neuroligin is an extensively studied family of CAMs
that fits this profile (Ichtchenko et al., 1995). Members
of the neuroligin family interact withb-neurexin, their pre-
synaptic ligand, and with PSD-95, an abundant scaffold-
ing protein in the postsynaptic density (PSD) (Ichtchenko
et al., 1996; Irie et al., 1997). The b-neurexin-neuroligin
complex has been shown to be sufficient to induce
both pre- and postsynaptic differentiation (Chih et al.,
2005; Dean et al., 2003; Graf et al., 2004; Nam and
Chen, 2005; Scheiffele et al., 2000). Intriguingly, different
isoforms of the neuroligin family display different subcel-
lular localizations in neurons; for instance, neuroligin-1
distributes to excitatory synapses, while neuroligin-2 is
detected at inhibitory synapses (Chih et al., 2005; Graf
et al., 2004; Levinson et al., 2005; Song et al., 1999;
Varoqueaux et al., 2004). Collective data from overex-
pression, dominant-negative inhibition, siRNA knock-
down, neuron-fibroblast coculture, and bead aggrega-
tion experiments indicate that each neuroligin isoform
plays a different role in the differentiation of excitatory
and inhibitory synapses (Chih et al., 2005; Graf et al.,
2004; Levinson et al., 2005; Nam and Chen, 2005; Prange
et al., 2004; Sara et al., 2005). These results strongly sug-
gest that the neuroligin family members are key regula-
tors of synaptic differentiation. However, considering
the huge diversity of neuronal synapses, the cell biolog-
ical steps that link initial neuron-to-neuron contacts to
the establishment of early synapses and their subse-
quent differentiation may be far more complex than our
current understanding.
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of excitatory synapses (Funke et al., 2004; Kim and
Sheng, 2004). In support of this, PSD-95 overexpression
has been shown to promote the maturation of excitatory
synapses (El-Husseini et al., 2000a). Conversely, down-
regulation of PSD-95 by RNA interference and SNK (a
polo-like inducible kinase) reduces excitatory synapses
and synaptic responses (Nakagawa et al., 2004; Pak
and Sheng, 2003; Prange et al., 2004). In addition, PSD-95
redirects neuroligin-2, which is mainly present at inhibi-
tory synapses (Chih et al., 2005; Graf et al., 2004; Levin-
son et al., 2005; Prange et al., 2004), to excitatory synap-
ses (Graf et al., 2004; Prange et al., 2004), inducing a shift
in the balance between excitatory and inhibitory synap-
ses. This suggests that the level of endogenous PSD-
95 in neurons, which can be dynamically regulated by
synaptic activity (Bao et al., 2004; Pak and Sheng,
2003), is a key determinant of the overall excitability of
the neuron.
Of note, electron microscopic analysis has indicated
that PSD-95 is located close to the postsynaptic mem-
brane (Valtschanoff and Weinberg, 2001), suggesting
that PSD-95 is located in an ideal position to link synaptic
adhesion events to postsynaptic protein clustering and
differentiation. Using the PDZ domains of PSD-95 as
bait in yeast two-hybrid screens, we identified a family
of CAM-like molecules, which was recently reported as
SALM (Wang et al., 2006). Data from experiments includ-
ing overexpression, bead aggregation, and siRNA
knockdown of the SALM2 isoform strongly suggest
that SALM2 selectively promotes the differentiation of
excitatory synapses.
Results
Identification of SALM, a PSD-95-Interacting Family
of Cell Adhesion-like Molecules
Using the PDZ domains of PSD-95 as bait in yeast two-
hybrid screens of human cDNAs, we identified two differ-
ent but highly related cell adhesion-like molecules
(KIAA1246 and KIAA1484). Database searches using
these two proteins identified two additional related pro-
teins. Because these proteins were designated SALMs
(for synaptic adhesion-like molecules) in the database
and a recent paper (Wang et al., 2006), we adopted this
nomenclature. However, our fourth protein was different
from SALM4 and is thus designated SALM5. Invertebrate
homologs of SALM were not found, suggesting that the
SALM family has functions unique to vertebrates. The
SALM family proteins are type I membrane proteins that
share a similar domain structure. Extracellularly, they
contain typical cell adhesion domains including leucine-
rich repeats, an immunoglobulin domain, and a fibronec-
tin type III domain. The transmembrane domain is then
followed by a C-terminal PDZ domain binding motif (ab-
sent in SALM5) (Figure 1A and Figure S1A). Interestingly,
the cytosolic regions of the SALM family proteins share
little amino acid (aa) sequence identity (Figure S1B).
The overall domain structure of SALM is similar, although
not identical, to that of AMIGO, a family of CAMs impli-
cated in axon tract development (Kuja-Panula et al.,
2003), and NGL-1, a neuronal CAM that regulates the out-
growth of thalamocortical axons (Lin et al., 2003). AMIGO
family members and NGL-1 have leucine-rich repeatsand an immunoglobulin domain, but lack the fibronectin
type III domain of SALM family members. The leucine-
rich repeats of SALM resemble those found in the Slit
family of axon-guidance proteins (Rothberg et al., 1988)
and the Nogo-66 receptor (Fournier et al., 2001). Yeast
two-hybrid, GST pull-down, in vitro coimmunoprecipita-
tion, and coclustering assays consistently showed that
SALM1, -2, and -3 (but not SALM5) interacted with
PSD-95 and other PSD-95 family proteins (PSD-93/chap-
syn-110, SAP97, and SAP102) (Figures 1B–1H). The ecto-
domain of AMIGO has been shown to mediate homo-
philic interactions (Kuja-Panula et al., 2003). However,
the ectodomain of SALM2 fused to alkaline phosphatase
did not interact with SALM2 displayed on the surface of
heterologous cells (data not shown), suggesting that
SALM2 does not mediate homophilic adhesion.
mRNA and Protein Expression Patterns of SALM
Northern blot analysis revealed that SALM2 mRNAs were
mainly detected in rat brain and testis (Figure 2A). In situ
hybridization showed that the mRNAs of the SALM iso-
forms were widely but distinctly expressed in various
rat brain regions, including cerebral cortex, hippocam-
pus, dentate gyrus, and olfactory bulb (Figure 2B). To
study protein expression patterns of SALM2, we gener-
ated a SALM2-specific antibody that does not recognize
other SALM isoforms in both immunoblot and immuno-
histochemistry conditions (Figure S2). An immunoblot
analysis revealed that SALM2 proteins are mainly
expressed in the brain (Figure 2C). Two major SALM2
protein bands were detected in rat brain (w105 and 80
kDa; Figure 2C). The top band, which is similar in size
to SALM2 expressed in HEK293T cells (data not shown),
appears to be N-glycosylated, as evidenced by the fact
that the size was reduced following PNGase F digestion
(Figure 2D). The expression levels of SALM2 proteins
were found to increase steadily during postnatal rat brain
development, parallel to the expression levels of PSD-95
(Figure 2E). SALM2 was mainly detected in synaptic
plasma membrane (LP1) and light membrane (P3) brain
fractions (Figure 2F) and was highly enriched in PSD
fractions (Figure 2G).
In Vivo Association of SALM2 and PSD-95
at Excitatory Synapses
In rat brain sections, SALM2 proteins were widely ex-
pressed in brain regions, including the cortex, hippo-
campus, and cerebellum (Figures S3A–S3C). SALM2 sig-
nals were detected in cortical pyramidal neurons,
hippocampal CA3 and CA1 neurons, and cerebellar Pur-
kinje neurons (Figures S3D–S3G). Subcellularly, SALM2
signals were associated with cell bodies, neurites, and
punctate structures (Figures S3D–S3G). In high-resolu-
tion images, SALM2 clusters colocalized with or were
closely apposed to synapsin I (a presynaptic marker;
Figure S3H), suggesting that SALM2 proteins are present
at synaptic sites.
In cultured hippocampal neurons, SALM2 colocalized
with PSD-95 and vGlut1, which are excitatory post- and
presynaptic markers, respectively (Figures 3A and 3B).
In contrast, SALM2 did not colocalize with gephyrin
and VGAT, which are inhibitory post- and presynaptic
markers, respectively (Figures 3C and 3D). Notably,
some SALM2 signals were detected in MAP2 (a marker
SALM Regulates Excitatory Synaptic Differentiation
235Figure 1. SALM Is a Family of Cell Adhesion-like Molecules that Interacts with PSD-95
(A) Domain structure of SALM2. SP, signal peptide; LRR, leucine rich repeat; NT, N-terminal domain; CT, C-terminal domain; Ig, immunoglobulin
domain; FNIII, fibronectin type-III domain; TM, transmembrane domain; PB, PDZ domain binding motif; ESTV*, the last four aa residues of SALM2.
(B) Interaction of SALM isoforms with the PDZ domains of PSD-95 family proteins in the yeast two-hybrid assay. pBHA, bait vector; pGAD, prey
vector; WT, wild-type; V788A, V766A, and V636A, mutant SALM isoforms in which the last residue was changed into alanine. Only b-gal results are
shown for simplicity (histidine growth gave similar results).
(C) Interaction of SALM isoforms with PSD-95 family proteins in the pull down assay. EGFP-tagged cytosolic regions of SALM isoforms expressed
in heterologous cells were pulled down by full-length PSD-95 family proteins fused to GST. DC, a mutant SALM that lacks the last 3 residues.
(D–G) Coimmunoprecipitation of SALM2 with PSD-95 family proteins in heterologous cells. HEK293 cells transfected (Expression) with SALM2
(untagged) and the indicated PSD-95 family protein constructs were immunoprecipitated (IP) and immunoblotted with the indicated antibodies.
Input, 5%.
(H) Coclustering between SALM2 and PSD-95. COS7 cells expressing SALM2 (untagged), PSD-95, or both, were labeled with the antibodies
indicated. In the case of double labeling, an active channel is indicated by underline.for dendrites)-negative axons (data not shown), suggest-
ing that SALM2 may perform some presynaptic func-
tions perhaps by interacting with members of the PSD-
95 family that are present in both dendrites and axons
such as SAP97 and SAP102 (El-Husseini et al., 2000b;
Muller et al., 1995).
Immunoprecipitation experiments showed that
SALM2 forms an in vivo complex with PSD-95 family pro-
teins, including PSD-95, chapsyn-110/PSD-93, and
SAP97, but not with negative control PDZ proteins
such as S-SCAM and CASK (Figures 3E–3H). In addition,
SALM2 coprecipitated with GluR1 and GluR2 subunits of
AMPA receptors and the NR1 subunit of NMDA recep-
tors (Figure 3E). Together, these results indicate that
SALM2 associates with PSD-95 at excitatory synapses.
SALM2 Expressed in Fibroblasts Does Not Induce
Presynaptic Differentiation in Contacting Neurites
Because SALM2 contains typical adhesion domains, in-
teracts with PSD-95, and is present at excitatory synap-
ses, we hypothesized that SALM2 may promote excit-
atory synaptic differentiation. Previous reports have
shown that heterologous cells expressing neuroligin or
SynCAM can induce presynaptic differentiation in con-
tacting axons of cocultured neurons (Biederer et al.,2002; Scheiffele et al., 2000). Conversely, heterologous
cells expressing b-neurexin were shown to induce post-
synaptic differentiation in contacting dendrites (Graf
et al., 2004; Nam and Chen, 2005). When we tried similar
experiments, however, SALM2-expressing COS cells
did not induce detectable presynaptic differentiation in
contacting axons of cocultured hippocampal neurons
(data not shown), suggesting that SALM2 may not induce
de novo presynaptic differentiation. Because SALM2
does not seem to mediate homophilic adhesion, and
we have not yet identified any presynaptic SALM2 ligand,
we could not test whether a presynaptic ligand could
induce postsynaptic differentiation in this assay.
Overexpression of SALM2 Leads to Increases in the
Number of Excitatory Synapses andDendritic Spines
Another way of demonstrating the function of a synaptic
CAM is to overexpress the CAM in cultured neurons and
monitor changes in excitatory and inhibitory synapses
(Chih et al., 2005; Levinson et al., 2005; Prange et al.,
2004; Sara et al., 2005). To this end, we examined the ef-
fect of SALM2 overexpression in cultured hippocampal
neurons (days in vitro or DIV12–18), by using an expres-
sion construct that increases SALM2 expression by
130% in neurons (n = 13; data not shown). SALM2
Neuron
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(A) Tissue distribution of SALM2 mRNAs in Northern blot analysis. Sk. muscle, skeletal muscle.
(B) Distribution of SALM family mRNAs revealed by in situ hybridization analysis. OB, olfactory bulb; Cx, cortex; Hc, hippocampus; Cb, cerebel-
lum. Scale bar, 6 mm.
(C) Tissue distribution pattern of SALM2 proteins in immunoblot analysis.
(D) N-glycosylation of SALM2. The crude synaptosomal fraction of rat brain was subjected to PNGase F digestion, followed by immunoblotting
with the indicated antibodies. SynPhy, synaptophysin (positive control).
(E) Expression levels of SALM2 during postnatal rat brain development. P, postnatal; wks, weeks. Identical amounts of proteins were loaded for
each lane.
(F) Distribution of SALM2 in biochemical rat brain fractions. H, homogenates; P2, crude synaptosomes; S2, supernatant after P2 precipitation;
S3, cytosol; P3, light membranes; LP1, synaptosomal membranes; LS2, synaptosomal cytosol; LP2, synaptic vesicle-enriched fraction. Identical
amounts of proteins were loaded for each lane.
(G) Enrichment of SALM2 in PSD fractions; extracted with Triton X-100 once (PSD I) or twice (PSD II) or with Triton X-100 and Sarkosyl (PSD III).
Br., brain; syn, synaptosome. The amounts of loaded proteins are indicated.overexpression significantly increased the number of
excitatory synapses, which were defined by vGlut1 (an
excitatory presynaptic marker)-positive PSD-95 clusters
(Figures 4A and 4B), and dendritic spines, defined by
dendritic protrusions (0.5–3.0 mm in length) positive for
both PSD-95 and vGlut1 (Figures 4A and 4C). In contrast,
expression of a SALM2 mutant lacking the C-terminal
PDZ binding motif (SALM2 DC) in neurons did not
increase the number of excitatory synapses and even
reduced the number of spines in a dominant-negative
manner (Figures 4A–4C). The limited dominant effect of
SALM2 DC on excitatory synapses (Figures 4A–4C) sug-
gests that SALM2 may be more important for the differ-
entiation of dendritic spines than excitatory synapses,
although both parameters were reduced by high-level
overexpression of SALM2 DC (see below). While affect-
ing excitatory synapses, overexpression of SALM2 or
SALM2DC had no effect on the number of inhibitory syn-
apses, defined by VGAT (an inhibitory presynaptic
marker)-positive gephyrin (an inhibitory postsynaptic
marker) (Figures 4D and 4E). These results suggest that
SALM2 promotes the differentiation of excitatory, but
not inhibitory, synapses through a mechanism that
requires PSD-95 interaction.
In contrast to its positive effects on the number of
excitatorysynapses and dendritic spines,SALM2overex-
pression did not significantly change the frequency or
amplitude of miniature excitatory postsynaptic currents
(mEPSCs) or miniature inhibitory postsynaptic currents
(mEPSCs) (Figures 4F–4I). In addition, SALM2 overex-pression did not increase the number of GluR1 (surface)
or NR1 clusters (Figure S4). These results suggest that
SALM2 overexpression preferentially promotes the mor-
phological differentiation of excitatory synapses.
The lack of neuroligin-like synaptogenic activity in
SALM2 suggests that it might function as a synapse dif-
ferentiating factor, which should have a greater influence
on neurons at late stages than at early stages. To explore
this possibility, we compared the effects of SALM2 over-
expression on early-stage versus late-stage neurons. Of
note, SALM2 overexpression at early stages (DIV6–12)
did not significantly increase the number of excitatory
synapses (Figures S5A–S5C), in contrast to the signifi-
cant effects at late stages (DIV12–18; Figures 4A–4C).
These results suggest that SALM2 has a greater influ-
ence on excitatory synaptic differentiation at late stages.
Mislocalized Expression of SALM2 Disrupts
Excitatory Synapses and Dendritic Spines
In a previous study, mislocalized expression of neuroli-
gin-2 was shown to disrupt postsynaptic protein cluster-
ing and synaptic transmission (Graf et al., 2004). We
hypothesized that, if SALM2 is an important regulator
of synaptic differentiation, high-level and mislocalized
expression of SALM2 should disperse postsynaptic
proteins into extrasynaptic sites and thus inhibit the dif-
ferentiation of excitatory synapses. To this end, we
first generated a SALM2 expression construct that
drives approximately 5- and 4-fold higher SALM2 ex-
pression in heterologous cells and neurons, respectively
SALM Regulates Excitatory Synaptic Differentiation
237Figure 3. SALM2 Colocalizes and Associates
with PSD-95 at Excitatory Synapses
(A–D) Localization of SALM2 at excitatory
synapses. Cultured hippocampal neurons
(DIV21) were labeled by double immunofluo-
rescence staining for SALM2 and the indi-
cated subcellular markers. Scale bar, 10 mm.
(E–H) In vivo coimmunoprecipitation between
SALM2 and PSD-95 family proteins. Deter-
gent lysates of the crude synaptosomal frac-
tion of adult rat brain were immunoprecipi-
tated with antibodies against SALM2 (E),
PSD-95 family proteins (F–H). Rb or Gp, rabbit
and guinea pig control antibodies; NMDAR1,
NR1 subunit of NMDA glutamate receptors;
GluR1 and GluR2, subunits of AMPA gluta-
mate receptors. Input, 5%.(data not shown). High-level and mislocalized expres-
sion of SALM2 by this construct in cultured hippocampal
neurons (DIV14–16) caused a marked reduction in the
number of excitatory synapses and dendritic spines,
compared to the overexrepssion of CD8 (an unrelated
T cell surface antigen), often leading to the dispersion
of very small clusters of PSD-95 in the dendritic trunk
(Figures 5A–5C). Notably, mislocalized expression of
SALM2 resulted in an increase in the number of inhibitory
synapses (Figures 5D and 5E). It has been shown that
PSD-95 promotes redistribution of neuroligin-2 from in-
hibitory synapses to excitatory synapses, changing the
ratio of excitatory to inhibitory synapses (Graf et al.,
2004; Prange et al., 2004). A possible explanation for
the increase in inhibitory synapses is that SALM2 overex-
pression-induced disruption of excitatory synapses
might have caused the release of inhibitory synapse-en-
hancing molecules sequestered at excitatory synapses
such as neuroligin-2.
In addition to wild-type SALM2, we also examined the
effects of high-level overexpression of SALM2 DC. Sim-
ilar to the effects of wild-type SALM2, SALM2DC caused
a marked decrease in the number of excitatory synapses
and dendritic spines as well as an increase in the number
of inhibitory synapses (Figures 5A–5E). This suggests
that regions of SALM2 other than the PSD-95 binding C
terminus are sufficient to exert the dominant-negative ef-
fects, although the importance of the C terminus cannot
be excluded. Together, these results, along with the C
terminus-dependent promotion of excitatory synapses
by moderate overexpression of SALM2 (Figures 4A–
4C), suggest that both the C terminus and the non-C-
terminal regions of SALM2 contribute to SALM2-depen-
dent synaptic differentiation.Direct Aggregation of SALM2 Induces Clustering
of Excitatory Postsynaptic Proteins
As our results suggested that SALM2 promotes excit-
atory synaptic differentiation, we used a bead aggrega-
tion assay to examine whether SALM2 is capable of driv-
ing postsynaptic differentiation at excitatory synapses.
Cultured neurons expressing N-terminally ECFP-tagged
SALM2 were incubated with beads coated with EGFP
antibodies. Robust clustering of SALM2 was observed
at sites of bead aggregation on dendrites (61.1%6 7.2%
of aggregated beads were SALM2-positive, n = 20 cells;
Figure 6). This SALM2 clustering induced coclustering
of PSD-95 (34.5%6 5.5% of bead-induced SALM2 clus-
ters were PSD-95-positive; n = 15 cells; Figure 6A). The
SALM2 and PSD-95 clusters were largely negative for
synapsin I (5.6% 6 2.9% of bead-induced SALM2 clus-
ters were synapsin I-positive, n = 10 cells; Figure 6A),
indicating that the SALM2 and PSD-95 clusters were
not induced by interneuronal synapses. In contrast,
SALM2 DC, which does not bind PSD-95, minimally in-
duced coclustering of PSD-95 (3.3% 6 1.3% of bead-
induced SALM2 DC clusters were PSD-95-positive, n = 10;
Figure 6B), suggesting that PSD-95 coclustering oc-
curs through the interaction of the SALM2 C terminus
with PSD-95. In addition to PSD-95, SALM2 aggregation
induced coclustering of GKAP (36.3% 6 6.7%, n = 10;
Figure 6C), a PSD-95-associated PSD protein (Kim
et al., 1997). SALM2 also induced coclustering of
AMPA receptors (GluR1) and, to a lower level, NMDA re-
ceptors (NR1), but their coclustering efficiencies were
smaller than those of PSD-95 and GKAP, as determined
by their fluorescence intensities normalized to the aver-
age dendrite intensity (GluR1, 1.77 6 0.14, n = 20 cells;
NR1, 1.36 6 0.26, n = 18; PSD-95, 3.02 6 0.49, n = 16;
Neuron
238Figure 4. Overexpression of SALM2 Leads to Increases in the Number of Excitatory Synapses and Dendritic Spines
(A) Cultured hippocampal neurons were transfected with pIRES-EGFP- SALM2, pIRES-EGFP- SALM2DC, or pIRES-EGFP alone (DIV 12-18), and
immunostained triply for EGFP, PSD-95, and vGlut1. Scale bar, 10 mm.
(B and C) Quantitation of the effect of SALM2 expression on the number of excitatory synapses (vGlut1-positive PSD-95 clusters; B) and dendritic
spines (vGlut1- and PSD-95-positive dendritic protrusions; [C]). Histograms show mean 6 SEM (n = 46 cells for pIRES-EGFP alone and pIRES-
EGFP-SALM2 and 20 cells for pIRES-EGFP-SALM2 DC, **p < 0.01; ***p < 0.0001, ANOVA, Tukey’s test).
(D) Cultured neurons were transfected with pIRES-EGFP-SALM2, pIRES-EGFP alone, or pIRES-EGFP-SALM2 DC, and immunostained triply for
EGFP, gephyrin, and VGAT.
(E) Quantitation of the effect of SALM2 expression on the number of inhibitory synapses (VGAT-positive gephyrin clusters). Mean6 SEM (n = 66
cells for pIRES-EGFP alone, 66 for pIRES-EGFP-SALM2, and 30 for pIRES-EGFP-SALM2 DC).
(F and G) Sample traces of mEPSCs (F) and mIPSCs (G) in cultured hippocampal neurons expressing pIRES-EGFP-SALM2 and pIRES-EGFP
alone (DIV12–18).
(H and I) Quantitation of the effects of SALM2 expression on the frequency (H) and amplitude (I) of mEPSCs and mIPSCs. Mean 6 SEM (n = 11
cells for mEPSCs and 10 cells for mIPSCs). The change in mIPSC frequency was nonsignificant (p = 0.128; Student’s t test).GKAP, 2.2260.18, n = 10; Figures 6D and 6E). In contrast
to excitatory postsynaptic proteins, the beads minimally
induced gephyrin coclustering (4.9% 6 2.4% of SALM2
clusters were gephyrin positive, n = 10 cells; Figure 6F).
These results suggest that aggregation of SALM2 is suf-
ficient to drive the clustering of excitatory, but not inhib-
itory, postsynaptic proteins.
Knockdown of SALM2 by siRNA Leads to the Loss of
Excitatory Synapses and Dendritic Spines
We then tested the effects of siRNA knockdown of
SALM2 on excitatory and inhibitory synapses. A
SALM2 siRNA construct reduced SALM2 expression in
heterologous cells by 35% (Figure S6A), and decreased
the expression of exo- and endogenous SALM2 in cul-
tured neurons by 47% and 72%, respectively (Figures
S6B and S6C). SALM2 knockdown by this siRNA con-struct caused a significant decrease in the number of ex-
citatory synapses and dendritic spines, often leading to
the dispersion of very small clusters of PSD-95 in the
dendritic trunk (Figures 7A–7C; DIV16/17–21), but did
not affect the number of inhibitory synapses (Figures
7D and 7E). SALM2 knockdown also reduced the total
amount of PSD-95 immunofluorescence signals normal-
ized to the dendritic area byw3 folds (control, 1022.036
121.18 in arbitrary unit, n = 19 cells; SALM2 knockdown,
332.63 6 113.48, n = 18, p < 0.001), suggesting that
SALM2 might be involved in the synaptic localization
and stabilization of PSD-95, although the signals for syn-
aptically localized PSD-95 clusters are often exagger-
ated compared with dispersed signals. In addition,
SALM2 knockdown significantly reduced the number of
both GluR1 (surface) andNR1 clusters, showing agreater
effect on GluR1 (Figure S7).
SALM Regulates Excitatory Synaptic Differentiation
239Figure 5. Mislocalized Expression of SALM2 Disrupts Excitatory Synapses and Dendritic Spines
(A) Cultured hippocampal neurons transfected with GW1 SALM2 (a high-level expression construct; DIV14–16), HA-CD8, or GW1 SALM2 DC,
were triply stained for SALM2, PSD-95, and vGlut1. Scale bar, 5 mm.
(B and C) Quantitation of the effects of mislocalized expression of SALM2 and SALM2 DC on excitatory synapses (B) and dendritic spines (C).
Mean 6 SEM (n = 25 cells for CD8, 30 for SALM2, and 28 for SALM2 DC, ***p < 0.0001, ANOVA Tukey’s test).
(D) Cultured hippocampal neurons transfected with GW1 SALM2, HA-CD8, or GW1 SALM2 DC (DIV14–16) were triply stained for SALM2,
gephyrin, and VGAT.
(E) Quantitation of the effects of mislocalized expression of SALM2 and SALM2 DC on inhibitory synapses. Mean6 SEM (n = 16 cells for CD8, 20
for SALM2, and 17 for SALM2 DC, *p < 0.05, **p < 0.01, ANOVA Tukey’s test).Consistent with our data from morphological mea-
surements, SALM2 knockdown in cultured hippocampal
neurons resulted in a decrease in the frequency, but not
amplitude, of mEPSCs (Figures 7F, 7H, and 7I; DIV 16/17–
21). In contrast, SALM2 knockdown had no effect on the
frequency or amplitude of mIPSCs (Figures 7G–7I).
Taken together, these results suggest that SALM2 is
important for the maintenance of excitatory, but not
inhibitory, synapses.
These results appear to be caused by specific degra-
dation of SALM2 mRNAs, as evidenced by the observa-
tion that the SALM2 siRNA-induced decreases in the
number of excitatory synapses and dendritic spines
could be reversed by cotransfection of an siRNA-resis-
tant SALM2 rescue construct (Figures S6D and S8). In
addition, a SALM2 siRNA with a point mutation, which
does not reduce SALM2 expression in heterologous cells
(data not shown), did not induce any significant changes
in the number of excitatory synapses or dendritic spines
or the frequency or amplitude of mEPSCs (Figure S9),
further supporting the specific action of the SALM2
siRNA.
We also compared the effects of SALM2 knockdown
on early-stage neurons with those on late-stage neu-
rons. SALM2 knockdown in neurons at early stages
(DIV7–12) significantly reduced the number of excit-
atory synapses (Figure S10), but to a lesser extent
than late stages (DIV16/17–21; Figures 7A and 7B).
These results suggest that SALM2 is more important
for the maintenance of excitatory synapses in neurons
at late stages.Discussion
Regulation of the Differentiation of Excitatory
Synapses by SALM2
We herein identified a family of cell adhesion-like mole-
cules directly associating with PSD-95. Several lines of
evidence indicate that SALM2 is an important regulator
of the differentiation of excitatory, but not inhibitory, syn-
apses: (1) SALM2 is present at excitatory synapses;
(2) SALM2 is enriched in the PSD and biochemically asso-
ciates with PSD-95, a key scaffolding molecule at excit-
atorysynapses; (3) moderateoverexpression ofSALM2 in-
creases the number of excitatory synapses and dendritic
spines; (4) mislocalized expression of SALM2 reduces the
number of excitatory synapses; (5) bead aggregation of
SALM2 is sufficient to induce the clustering of excitatory
postsynaptic proteins including PSD-95, GKAP, and
AMPA receptors; and (6) siRNA knockdown of SALM2 re-
duces the number of excitatory synapses and dendritic
spines and the frequency of mEPSCs. These results
strongly suggest that SALM2 is involved in the regulation
of excitatory, but not inhibitory, synaptic differentiation.
Our results indicate that moderate overexpression of
SALM2 increases the number of excitatory synapses
and dendritic spines but does not increase the frequency
or amplitude of mEPSCs. This suggests that additional
SALM2 expression above the physiological range is suffi-
cient to induce morphological differentiation of excitatory
synapses. In addition, SALM2 siRNA knockdown de-
creases both the number of excitatory synapses and den-
dritic spines and the frequency of mEPSCs, suggesting
Neuron
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Cultured hippocampal neurons expressing N-terminally ECFP-tagged SALM2 (A and C–F), or SALM2 DC ([B]; DIV12–14), were incubated with
neutravidin beads coated with biotin-conjugated EGFP antibodies and visualized at DIV15 by triple immunofluorescence staining for ECFP, syn-
apsin I (Syn), and the indicated proteins including PSD-95 ([A and B]; PSD), GKAP (C), GluR1 (D), NR1 (E) and gephyrin ([F]; Geph). Synapsin I
staining was replaced with vGlut1 staining in GluR1 coclustering experiments (D) due to antibody incompatibility in triple staining. Beads
were visualized by DIC imaging. The area indicated by an arrow in the upper panels is enlarged in the bottom panels. Scale bar, 5 mm.that SALM2 is required for both morphological and func-
tional differentiation of excitatory synapses. Together,
these data suggest that SALM2 is both necessary and
sufficient for the differentiation of excitatory synapses.
Mechanisms by which SALM2 Regulates Excitatory
Synaptic Differentiation
How might SALM2 regulate the differentiation of excit-
atory synapses? Given that the extracellular portion of
SALM2 contains cell adhesion domains, and the C-termi-
nal tail of SALM2 interacts with PSD-95, SALM2 might
plausibly promote synaptic differentiation by simulta-
neously interacting with both a presynaptic ligand and
PSD-95 in a fashion similar to that of neuroligin (Chih
et al., 2005; Dean et al., 2003; Graf et al., 2004; Ichtchenko
et al., 1996; Irie et al., 1997; Nam and Chen, 2005; Scheif-
fele et al., 2000). A result contradicting this hypothesis is
that SALM2 expressed in heterologous cells does not in-
duce presynaptic differentiation in contacting axons of
cocultured neurons, suggesting that SALM2 may not in-
duce presynaptic differentiation through a trans-synap-
tic adhesion. However, this negative result could also
be caused by the choice of an incorrect type of cocul-
tured neuron, an inappropriate SALM2 splice variant, or
insufficient posttranslational modification of SALM2 in
heterologous cells. Furthermore, it remains possible
that as yet unknown presynaptic ligands could induce
the clustering of SALM2 and SALM2-associated post-
synaptic proteins. Indeed, this possibility is not inconsis-
tent with the results from our overexpression, bead
aggregation, and siRNA knockdown experiments. If
this sort of trans-synaptic interaction exists, our obser-vation that the ectodomain of SALM2 does not bind to
SALM2 indicates that SALM2 may mediate heterophilic
adhesion.
It is also possible that, rather than functioning in paral-
lel with neuroligin, SALM2 promotes excitatory postsyn-
aptic differentiation after trans-synaptic adhesion is
established by ‘‘early’’ CAMs such as neuroligin. In sup-
port of this possibility, overexpression or siRNA knock-
down of SALM2 had stronger effects on neurons at late
stages. If this is the case, the presence of PSD-95 in
the neuroligin-PSD-95 complex at early synapses may
promote SALM2 recruitment through the PDZ interac-
tion. In agreement with this, the C terminus of SALM2
was required for synaptic differentiation in the overex-
pression experiments. Once docked at synaptic sites,
SALM2 and PSD-95 may mutually promote their synaptic
recruitment and stabilization, as suggested by the
SALM2 knockdown-induced dispersion of PSD-95 into
small dendritic clusters and reduction in the total amount
of PSD-95. In addition, PSD-95 may couple SALM2 to
various PSD-95-associated postsynaptic proteins to fa-
cilitate the differentiation of early synapses. This possi-
bility is supported by the fact that bead aggregation of
SALM2 induces coclustering of PSD-95-associated
GKAP.
In addition to the PSD-95 binding C terminus, other re-
gions of SALM2 seem to mediate SALM2-dependent
postsynaptic differentiation. In support of this, the dom-
inant-negative effects of high-level SALM2 overexpres-
sion were still observed with the mutant lacking the C ter-
minus, which may induce dispersion of some proteins
that bind to the non-C-terminal regions of SALM2 and
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241Figure 7. Knockdown of SALM2 by siRNA Leads to the Loss of Morphological and Functional Excitatory Synapses
(A) Cultured hippocampal neurons expressing pSUPER SALM2 (si-SALM2), or pSUPER alone (si-vec; DIV16/17–21), were triply stained for EGFP,
PSD-95, and vGlut1. Scale bar, 5 mm.
(B and C) Quantitation of the effects of SALM2 knockdown on the density of excitatory synapses (B) and dendritic spines (C). Mean6 SEM (n = 15
for si-vec and 21 for si-SALM2, ***p < 0.0001, Student’s t test).
(D) Cultured neurons expressing si-SALM2, or si-vec (DIV16/17–21), were triply stained for EGFP, gephyrin, and VGAT. Scale bar, 10 mm.
(E) Quantitation of the effect of SALM2 knockdown on the density of inhibitory synapses. Mean 6 SEM (n = 19 for si-vec and 18 for si-SALM2,
p = 0.41, Student’s t test).
(F and G) Sample traces of mEPSCs (F) and mIPSCs (G) in cultured hippocampal neurons expressing si-SALM2 or si-vec (DIV16/17–21).
(H and I) Quantitation of the effects of SALM2 knockdown on the frequency (H) and amplitude (I) of mEPSCs and mIPSCs. Mean 6 SEM (n = 10
cells for mEPSCs and 7 cells for mIPSCs, *p < 0.05, Student’s t test).contribute to the maintenance of excitatory synapses.
Such mechanisms have been seen in other synaptic
CAMs, i.e., N-cadherin and NCAM, which associate
with the actin cytoskeleton and various signaling mole-
cules through their cytosolic domain (Juliano, 2002;Scheiffele, 2003; Yap and Kovacs, 2003). In this context,
it should be noted that the cytosolic regions of the SALM
family proteins share essentially no sequence identity
except for their extreme PSD-95 binding C termini, sug-
gesting that they may have distinct functions.
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down results indicate that SALM2 preferentially associ-
ates with AMPA receptors and, to a lesser extent, with
NMDA receptors, suggesting that this mechanism may
contribute to SALM2-dependent postsynaptic differenti-
ation. Acquisition of AMPA receptors at NMDA receptor-
only silent synapses are implicated in synaptic plasticity
and postnatal development of excitatory synapses
(Bredt and Nicoll, 2003). Considering that SALM2 over-
expression and knockdown have stronger influences
on neurons at late stages, SALM2 may promote the mat-
uration of excitatory synapses primarily during the late
stages of neuronal development through mechanisms
including synaptic enrichment of AMPA receptors. In
support of the notion that adhesion molecules can regu-
late synaptic maturation, Dasm1, an Ig superfamily pro-
tein, has been shown to regulate excitatory synaptic
maturation by selectively acting on AMPA receptors,
but not NMDA receptors (Shi et al., 2004). It remains to
be determined whether synaptic localization of AMPA re-
ceptors is one of the major mechanisms for SALM2-de-
pendent synaptic differentiation and, if so, how SALM2
promotes synaptic AMPA receptor localization.
Other Implications of the Association of SALM2
with PSD-95
Several other inferences may be drawn from our obser-
vation of a direct association between SALM2 and
PSD-95. First, although the ultrastructural localization
of SALM2 could not be determined in the present study
due to the lack of a suitable antibody, the fact that
SALM2 is enriched in PSD fractions and associates
with PSD-95 suggests that SALM2 is likely to be present
at synaptic sites rather than in the puncta adherentia
junctions, which flank synaptic junctions and are similar
to epithelial adherence junctions (Yamagata et al., 2003).
Second, it should be noted that while both SALM and
neuroligin bind to PSD-95, the SALM family proteins
bind more strongly to the first and second PDZ domains
of PSD-95, whereas neuroligin preferentially binds to the
third PDZ domain (Irie et al., 1997; Song et al., 1999).
Thus, it is possible that SALM and neuroligin undergo
parallel and noncompetitive binding to PSD-95 to per-
form their specific functions.
And third, recent studies have shown that overexpres-
sion of PSD-95 promotes the localization of neuroligin-1
at excitatory synapses as well as the redistribution of neu-
roligin-2 from inhibitory to excitatory synapses (Graf et al.,
2004; Prange et al., 2004). Conversely, siRNA knockdown
of PSD-95 decreased the number of excitatory synapses
and concomitantly increased the number of inhibitory
synapses (Prange et al., 2004), suggesting that the
amount of PSD-95 in a neuron is a key factor in controlling
the balance between excitatory and inhibitory synapses
(Prange et al., 2004). Because our data indicate that
SALM2 binds to PSD-95 and regulates the differentiation
of excitatory synapses, it is conceivable that SALM2,
along with neuroligin, might be involved in the PSD-95-
dependent regulation of overall neuronal excitability.
Differential Characteristics of the SALM
Family Proteins
While we were revising the current paper, which iden-
tifies the SALM family and mainly focuses on SALM2,a similar study identifying the same SALM family was
published (Wang et al., 2006), in which SALM1 was
mainly characterized. Comparison of the two studies re-
veals that although SALM1 and SALM2 share various
features, including domain structure and interaction
with PSD-95, they also have interesting differences. Spe-
cifically, SALM1 mainly associates with NMDA recep-
tors, but not with AMPA receptors, whereas SALM2 as-
sociates with both NMDA and AMPA receptors, with
a stronger association with AMPA receptors. In addition,
SALM1 promotes neurite outgrowth in young neurons
but not in late-stage neurons. By contrast, SALM2 exerts
a greater influence on excitatory synapses of late-stage
neurons. Postnatal expression of SALM1 in rat brain pla-
teaus at approximately postnatal day 1 whereas that of
SALM2 increases steadily during postnatal develop-
ment. Structurally, the cytosolic regions of SALM1 and
SALM2 share essentially no identity except for their ex-
treme C termini. Therefore, SALM1 and SALM2 may dif-
ferentially act on different stages of synaptic develop-
ment (SALM1 on early and SALM2 on late stages)
through their differential interaction with glutamate re-
ceptors and cytosolic binding partners. These results
are reminiscent of the differential characteristics of the
isoforms in the PSD-95 or neuroligin family (Craig et al.,
2006; Dean and Dresbach, 2006; Kim and Sheng, 2004;
Levinson and El-Husseini, 2005).
In sum, our data suggest that SALM2 is an important
regulator of the differentiation of excitatory synapses.
A direction to pursue would be to understand detailed
mechanisms underlying the SALM2-dependent synaptic
differentiation. Other future studies may seek to identify
and characterize novel SALM ligands and explore
whether SALM is involved in the regulation of structural
and functional plasticity of synapses.
Experimental Procedures
Antibodies
GST- SALM2 (aa 551–766 containing the entire cytoplasmic region)
was used for immunization of a guinea pig (1348) and affinity-purified
using SulfoLink columns (Pierce). The following antibodies were de-
scribed previously: PSD-95 1402 (Choi et al., 2005), Chapsyn-110
(Kim et al., 1996), SAP97 (Kim et al., 1996), S-SCAM 1146 (Mok
et al., 2002), EGFP 1173 (Ko et al., 2003a), GKAP 1443 (Ko et al.,
2003b), CASK (Hsueh and Sheng, 1999), NMDAR1 (Sheng et al.,
1994). The other antibodies were purchased commercially: Myc
(Santa Cruz), FLAG (Sigma), PSD-95 (Affinity BioReagents), gephyrin
(Synaptic Systems), vGlut1 (Synaptic Systems), NR1 (Pharmingen),
GluR1 (Calbiochem), surface GluR1 (Oncogene), GluR2 (Chemicon),
VGAT (Synaptic Systems), synaptophysin (Sigma), synapsin I (Chem-
icon), and a-tubulin (Sigma).
cDNA Constructs
The PDZ2 domain of PSD-95 (aa 89–299) in the pBHA bait vector was
used to screen a human brain yeast two-hybrid cDNA contained in
the pACT2 prey vector (Clontech). Full-length rat SALM2 (aa 1–766)
was PCR-amplified from a rat brain cDNA library (Clontech) and
subcloned into GW1 (British Biotechnology) for high-level and mislo-
calized expressions. SALM2 DC (aa 1–762) was also subcloned into
GW1. For low-level expressions, rat SALM2 cDNAs (full-length and
DC) were subcloned into pIRES2-EGFP (Clontech). ECFP-tagged
SALM2 was generated by adding the ECFP cassette between aa
33 and 34 of GW1 SALM2. SALM1 (aa 586–788), SALM2 (aa 551–
766), SALM3 (aa 566–636), and SALM5 (aa 559–719) were subcloned
into pBHA. pGAD10 plasmids were previously described (Choi et al.,
2005; Mok et al., 2002). For pull-down assay, the cytoplasmic regions
of SALM1 (aa 586–788), SALM2 (aa 551–766), SALM3 (aa 546–636),
SALM Regulates Excitatory Synaptic Differentiation
243and SALM5 (aa 559–719) were subcloned into pEGFP-C1 (Clontech).
For short-interfering RNA (siRNA) knockdown of SALM2, pSUPER
SALM2 was generated by annealing oligonucleotides containing nt
245–263 (with the first nucleotide of the start codon as nucleotide
1) of the rat SALM2 cDNA (accession number, XM_344874; critical
19 nt sequence, GTCGAGACTTCGCCAATAT) and subcloning into
pSUPER.gfp/neo (OligoEngine) vector. A pSUPER SALM2 variant
with a point mutation was generated by mutating the 19-nt sequence
into GTCGAGACTTTGCCAATAT. SALM2 expression construct re-
sistant to siRNA was generated by introducing a point mutation at
residue 255 (C to T) using the QuickChange kit (Stratagene). The
following expression constructs have been described previously:
GW1-PSD-95 (Kim et al., 1995), GW1-Myc-chapsyn-110 (Hsueh
et al., 1997), EGFP-SAP97 (Choi et al., 2005), pFLAG-CMV2 SAP102
(Choi et al., 2005).
Deglycosylation Assays in Brains
Enzymatic deglycosylations were performed with rat P2 (crude
synaptosomes) fractions extracted with 1% deoxycholate (DOC)
using N-glycosidase/PNGase F (New England Biolabs) according
to the manufacturer’s instructions. Deglycosylations were analyzed
by immunoblotting with SALM2 (1348), or synaptophysin antibodies.
In Situ Hybridization Analysis
In situ hybridization was performed as described previously (Kim
et al., 2003). Brain sections (12 mm thick) from adult rats (6 weeks)
were used. SALM isoform-specific hybridization probes encompass-
ing the C-terminal region and the 30 untranslated region were prepared
from the following constructs: pGEM7zf containing nt 2126-2486 of
rat SALM2 (coding region is nt 1–2301) and rat SALM5 (the entire se-
quence of the BF544867 EST clone, corresponding to the last 174 nt
of the coding region and the first 301 nt of the 30 untranslated region;
full-length sequence of rat SALM5 cDNA is not available yet); pBlu-
script II containing nt 2214–2755 of rat SALM1 (coding region is nt
1–2415) and rat SALM3 (the entire sequence of the CB608382 EST
clone, corresponding to the last 246 nt of the coding region and the
first 286 nt of the 30 untranslated region). Antisense riboprobes
were prepared by RNA polymerase transcription using a Riboprobe
System (Promega) in the presence of a-35S-UTP.
Northern Blot Analysis
pGEM7zf SALM2 used in situ hybridization assays was used to gen-
erate SALM2-specific probe, which was labeled using a-32P-dCTP
and the Prime-a-Gene labeling system (Promega). This probe was
used to hybridize the rat multiple-tissue Northern membrane (Clon-
tech) in ExpressHyb solution following the manufacturer’s instruc-
tions (Clontech).
Brain Fractionation and Coimmunoprecipitation
Subcellular and PSD fractions of adult rat brain were prepared as
described (Carlin et al., 1980; Huttner et al., 1983). For developmental
studies, whole brain homogenates were prepared from the rat brains
at the ages of P1, P7, P14, P21, P29, and P42. In vivo coimmunpreci-
pitation was performed as described (Wyszynski et al., 1999). In brief,
the P2 fraction of adult rat brain was extracted in buffer containing
1% sodium deoxycholate and 50 mM Tris-HCl, pH 9.0, followed by
incubation with immunoprecipitation antibodies. For coimmunopre-
cipitation in heterologous cells, cells were extracted in phosphate-
buffered saline containing 1% Triton X-100.
Bead Aggregation Assays
Cultured neurons were transfected with ECFP-tagged SALM2 (wild-
type or DC) at DIV12. Neutravidin labeled FluoSpheres (Molecular
Probes; 1 mm diameter) were incubated with biotin-conjugated
anti-EGFP antibodies (Rockland) for 2 hr at room temperature. The
beads were resuspended with the conditioned medium and seeded
onto ECFP-SALM2 expressed neurons at DIV14. Neurons were main-
tained for 24 hr before triple immunofluorescence staining and DIC
imaging at DIV15.
Neuron Culture, Transfection, and Immunocytochemistry
Primary hippocampal cultures were prepared from embryonic day
(E) 18–19 rat hippocampi described previously (Ko et al., 2003a). Cul-
tured neurons were transfected using mammalian transfection kit(Invitrogen) and fixed with 4% paraformaldehyde/4% sucrose, per-
meabilized with 0.1% Triton X-100 in phosphate buffered saline,
and incubated with the specific primary and Cy3-, Cy5-, or FITC- con-
jugated secondary antibodies. For in vivo immunocytochemical
analysis, adult rat brain sections (50 mm) were permeabilized by incu-
bation in 50% ethanol. The following antibodies were used for immu-
nocytochemistry of transfected neurons and brain sections: SALM2
(3mg/ml), EGFP (1mg/ml), PSD-95 (Affinity BioReagent, 1:500), vGlut1
(1 mg/ml), gephyrin (1 mg/ml), and VGAT (1 mg/ml).
Image Acquisition and Quantification
Z-stacked fluorescent images were acquired using a confocal micro-
scope (LSM510 or PASCAL; Zeiss). The same parameter settings
were used for all scanning. Each experiment was repeated from three
to five times, and neuronal images for analysis were randomly se-
lected. All the morphometric measurements were performed using
the MetaMorph image analysis software (Universal Imaging). To de-
termine the density of synaptic protein clusters, one or two proximal
dendrites with the largest caliber were chosen and analyzed. Clus-
ters or puncta were defined as discrete regions of immunoreactivity
with at least 2-fold higher intensity than the background. The num-
bers of clusters were counted and normalized to 10 mm length of
dendrites after manual tracing and measurement in MetaMorph
software. Excitatory and inhibitory synapses were defined by
vGlut1-positive PSD-95 and vGAT-positive gephyrin clusters, re-
spectively. PSD-95 and VGAT clusters that are localized outside
the transfected neurons were not counted because they likely repre-
sent synaptic sites of nearby untransfected neurons. To determine
the spine density, spines were defined as dendritic protrusions
(0.5w3.0 mm length; with or without a head) that are positive for
both PSD-95 and vGlut1 (excitatory post- and presynaptic markers).
The density of spines from a single image frame were grouped and
averaged; means from multiple individual neurons were averaged
to obtain a population mean and SEM. All the values were expressed
as mean 6 SEM. Statistical significance was determined by Stu-
dent’s t test or ANOVA Tukey test.
Electrophysiology
EGFP-positive cultured hippocampal neurons transfected with
SALM2 moderate overexpression (pIRES-EGFP-SALM2) or SALM2
siRNA knockdown (pSUPER neo/GFP SALM2) constructs were
whole-cell voltage clamped at 270 mV. The extracellular solution
for whole-cell voltage clamp experiments contained (in mM): 150
NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 10 glucose, 10 HEPES (pH 7.4). The pi-
pette solution for mEPSC measurements contained (in mM): 115
CsMeSO3, 10 CsCl, 5 NaCl, 10 HEPES, 10 EGTA, 4 Mg-ATP, 0.3 Na-
GTP (pH 7.35). TTX (1 mM; Tocris) and bicuculine (40 mM; Tocris)
were added to the extracellular solution to block spontaneous action
potentials and mIPSCs. The pipette solution for mIPSC measure-
ments contained (in mM): 144 CsCl, 10 HEPES, 10 EGTA, 4 Mg-
ATP, 0.3 Na-GTP (pH 7.35). TTX (1 mM), APV (50 mM), and CNQX (10
mM) were added to the extracellular solution to block action poten-
tials and mEPSCs. All measurements were made using an Axopatch
200B amplifier (Axon instruments) at room temperature. Data were
acquired at 10 kHz and low-pass filtered at 1 kHz. Pipette resistances
were 4w8 MOhm, and input resistances were >100 MOhm. Data
were analyzed using Mini Analysis Program (Synaptosoft).
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/50/2/233/DC1/.
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